Pacific Biosciences of California (PACB) — Working Capital to Net Assets Ratio
Pacific Biosciences of California (PACB) has a Working Capital to Net Assets ratio of -812.4% as of June 2026. Working capital of $269.83 Million (current assets of $338.64 Million minus current liabilities of $68.81 Million) is measured against net assets of $-33.21 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see how large is Pacific Biosciences of California's balance sheet.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pacific Biosciences of California Working Capital to Net Assets (2008–2025)
This chart shows how Pacific Biosciences of California's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at -812.4%, reflecting working capital of $269.83 Million against net assets of $-33.21 Million USD. Explore Pacific Biosciences of California capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Pacific Biosciences of California (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pacific Biosciences of California from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read total liabilities of Pacific Biosciences of California for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 5993.9% | $320.62 Million | $5.35 Million | $375.03 Million | $54.42 Million | ▲ +5909.2 pp |
| 2024 | 84.8% | $429.38 Million | $506.59 Million | $495.68 Million | $66.30 Million | ▼ -7.5 pp |
| 2023 | 92.3% | $647.02 Million | $701.30 Million | $742.05 Million | $95.03 Million | ▼ -12.3 pp |
| 2022 | 104.6% | $588.74 Million | $562.90 Million | $852.07 Million | $263.33 Million | ▼ -25.6 pp |
| 2021 | 130.1% | $1.03 Billion | $790.99 Million | $1.10 Billion | $71.71 Million | ▲ +35.6 pp |
| 2020 | 94.5% | $317.08 Million | $335.49 Million | $355.59 Million | $38.50 Million | ▲ +36.4 pp |
| 2019 | 58.1% | $31.89 Million | $54.92 Million | $81.05 Million | $49.15 Million | ▼ -39.5 pp |
| 2018 | 97.6% | $111.31 Million | $114.06 Million | $131.66 Million | $20.35 Million | ▲ +5.5 pp |
| 2017 | 92.1% | $79.30 Million | $86.10 Million | $101.62 Million | $22.32 Million | ▲ +3.2 pp |
| 2016 | 88.9% | $75.24 Million | $84.67 Million | $109.01 Million | $33.77 Million | ▼ -31.6 pp |
| 2015 | 120.5% | $88.61 Million | $73.54 Million | $110.54 Million | $21.93 Million | ▼ -36.5 pp |
| 2014 | 157.0% | $86.27 Million | $54.95 Million | $117.76 Million | $31.49 Million | ▲ +6.8 pp |
| 2013 | 150.2% | $103.90 Million | $69.18 Million | $126.46 Million | $22.55 Million | ▲ +58.5 pp |
| 2012 | 91.7% | $100.26 Million | $109.38 Million | $115.00 Million | $14.74 Million | ▼ -2.5 pp |
| 2011 | 94.1% | $180.22 Million | $191.46 Million | $199.60 Million | $19.38 Million | ▼ -3.2 pp |
| 2010 | 97.3% | $272.27 Million | $279.87 Million | $293.11 Million | $20.84 Million | ▲ +145.5 pp |
| 2009 | -48.2% | $85.33 Million | $-177.12 Million | $93.75 Million | $8.42 Million | ▲ +61.3 pp |
| 2008 | -109.5% | $102.22 Million | $-93.39 Million | $106.93 Million | $4.70 Million | — |